搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
verywellhealth
1 天
Cymbalta vs. Effexor: Which Should You Choose?
Cymbalta is the brand name for duloxetine, and Effexor XR contains the active drug venlafaxine. These are prescription drugs called serotonin-norepinephrine reuptake inhibitors (SNRIs). They are used ...
3 天
on MSN
Genetic links to depression found in big global study, giving hope for new treatments
Study of 5 million people of all backgrounds finds variations in hundreds of genes; previous studies were on people of ...
FiercePharma
5 天
JPM25: Takeda spotlights 6 pipeline assets that could pull down up to $20B in collective ...
Among the myriad drugmakers laying out their plans for the future at this year’s J.P. Morgan Healthcare Conference, Takeda ...
Future Market Insights
5 天
Narcolepsy Treatment Industry to Reach USD 8,718.3 Million by 2034, Growing at a 5.1% CAGR
The narcolepsy treatment market is projected to grow from USD 5,301.6 million in 2024 to USD 8,718.3 million by 2034, at a ...
6 天
Hope for new depression treatments as scientists identify 300 new genetic risk factors
The largest and most diverse genetic study of depression has identified 300 new genetic risk factors for the condition across ...
6 天
British scientists discover way to predict who is most at risk of depression in major ...
Scientists said the British-led study provides more hope than ever before that the condition could be tackled through new ...
6 天
Study will spark rethink on drugs used to treat depression
The world’s largest genetic study into depression has uncovered life-changing discoveries that will revolutionise treatments ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈